{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-118989","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.856257+00:00","generated_at":"2026-05-16T14:05:04.485907+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Allarity Therapeutics CFO Jeffrey Ervin moves to full-time; gets $367.7K salary, $160K RSUs","bullets":["CFO Jeffrey S. Ervin transitioned from part-time to full-time effective December 3, 2025 under new employment agreement.","Annual base salary set at $367,700; eligible for annual bonus up to 30% of base salary.","Granted restricted stock units valued at $160,000, vesting in equal installments over three years.","Severance of six months base salary if terminated without cause, for good reason, or in connection with change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-118989","json":"https://secwatch.observer/filing/0001213900-25-118989.json","markdown":"https://secwatch.observer/filing/0001213900-25-118989.md","text":"https://secwatch.observer/filing/0001213900-25-118989.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025118989/0001213900-25-118989-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025118989/ea0268404-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:05:04.485907+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}